| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.37 | 1e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |